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L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells IRON CHELATORS WITH HIGH ANTIPROLIFERATION activities upregulate the expression of growth-inhibitory and metastatic suppressor genes mediated by hypoxia-inducible factor-1␣ (HIF-1␣)-dependent and independent mechanisms (16, 22) . LMimosine {(S)-␣-amino-␤-[1-(3-hydroxy-4-oxopyridine)] propionic acid; C 8 H 10 N 2 O 4 }, a plant amino acid, acts as an iron chelator and reversibly blocks mammalian cell proliferation at late G 1 phase (5) . An earlier study indicated that numbers of G 0 /G 1 cells were elevated after incubation with L-mimosine in human prostate carcinoma DU145 cells (32) . L-Mimosine also acts as a prolyl 4-hydroxylase inhibitor and has similar effects on the hypoxic induction of HIF-1␣ protein in human and rodent cells (3, 31) .
Expression of B-cell translocation gene 2 (Btg2) in cycling cells induced accumulation of growth-inhibitory forms of retinoblastoma protein and led to G 1 cell cycle arrest (8) . Immunohistochemistry and proliferative indexes of selected human prostate peripheral zone lesions indicated that a reduction in, or loss of, Btg2 expression is associated with progression to malignancy (6) . Additionally, forced overexpression of Btg2 attenuated cell proliferation in prostate carcinoma PC-3 cells, whereas thyroid hormone downregulated Btg2 gene expression in LNCaP cells (25) . A study using bone marrow-derived mesenchymal stem cells revealed that hypoxia induced mesenchymal stem cell differentiation in neuronlike cells by increasing the expression of Btg2 and decreasing cyclin D1 expression (20) .
N-myc downstream regulated gene 1 (Ndrg1) plays an important role in both androgen-induced cell differentiation and inhibition of prostate cancer metastasis (19, 28) . In vivo studies showed that expression of Ndrg1 was inversely associated with Gleason grading and overall survival rates of prostate cancer patients; moreover, Ndrg1 inhibited metastasis of prostate carcinoma PC-3 cells in vitro (1) . Previous study indicated that iron chelators induced Ndrg1 gene expression via the HIF-1␣ pathway in several types of cancer cells (34) .
The objectives of this study were to determine the regulatory effects of L-mimosine on HIF-1␣ and its association with gene expression of Btg2 and Ndrg1 in human prostate carcinoma cells.
MATERIALS AND METHODS
Cell culture and chemicals. Human prostate carcinoma LNCaP and PC-3 cells were obtained from the American Type Culture Collection (Manassas, VA) and were maintained as previously described (25) . Cells were incubated under normoxia using a standard CO 2 incubator at 37°C in a humidified atmosphere with 5% CO 2 and 95% room air (21% O 2) until the cells grew to 70%-80% confluence in RPMI-1640 medium with 10% fetal cal serum (FCS). On the day of hypoxic treatment (1% O 2, 5% CO2, and 94% N2), growth medium was switched to fresh medium with 10% FCS that had been preequilibrated in the hypoxic incubator (APM-30D, Astec, Fukuoka, Japan). Cells were then incubated in the hypoxic incubator for another 24 h. L-Mimosine, chetomin, dimethyloxalylglycine (DMOG), and ferric ammonium citrate (FAC) were purchased from Sigma Chemical (St. Louis, MO) and dissolved in the suggested solvent, according to the manufacturer's instructions. The bicinchoninic acid protein assay kit was purchased from Pierce Protein Research (Rockford, IL). FCS was purchased from HyClone (Logan, UT), and RPMI-1640 medium was purchased from GIBCO, Invitrogen (Grand Island, NY).
Cell proliferation assay with [
3 H]thymidine incorporation. Cell proliferation in response to L-mimosine was measured using a [ 3 H]thymidine incorporation assay, as previously described (12) . In this assay, 1 ϫ 10 4 cells were cultured in each well of a 12-well plate in RPMI-1640 medium with 10% FCS and different concentrations (0 -800 M) of L-mimosine. After the required incubation periods (24 and 48 h), 0.5 Ci/ml of [ 3 H]thymidine was added to each well of the 12-well plate. The cells were then incubated at 37°C in a humidified 5% CO2 atmosphere for 4 h. Cells were then washed twice with cold phosphate-buffered saline (PBS) and then with cold 5% trichloroacetic acid. Cells were lysed by adding 0.5 ml of 0.5 N NaOH. Then 400 l of the solubilized cell solution were mixed with 4 ml of scintillation cocktail and counted in a liquid scintillation analyzer (Packard BioScience, Meriden, CT). Each sample was tested in quadruplicate.
Flow cytometry. Cells were serum starved for 24 h and then cultured in RPMI-1640 medium with 10% FCS, with or without different concentrations (0 -800 M) of L-mimosine for another 24 h. The cells were collected, washed with cold PBS, and centrifuged. The pellet was resuspended in 300 l of cold PBS and fixed in ethanol. The cells were centrifuged at 300 g for 10 min, the fixative was discarded, and then the cells were washed with cold PBS. The cells were resuspended in 1 ml of PBS, and 50 l of Triton X-100 and 50 l of ribonuclease (10 mg/ml) were added and incubated for 1 h at 37°C. After further centrifugation, cells were resuspended in PBS, stained with propidium iodide, and incubated at 4°C overnight. Cell cycle analysis was performed using the FACS-Calibur cytometer and CellQuestPro software (BD Biosciences, San Jose, CA); the data were analyzed using ModFit LT Mac 3.0 software, as previously described (26) .
Immunoblot assay. Equal quantities of cell extract (40 g) were loaded onto 12% sodium dodecyl sulfate-polyacrylamide gels and analyzed using the Western lightning plus-Enhanced Chemiluminescence detection system (Perkin Elmer, Waltham, MA) and were viewed using ChemiGenius image capture system (Syngene, Cambridge, UK). Polyclonal rabbit anti-human Btg2 serum was prepared as previously described (25) . The blot membranes were probed with 1:500 HIF-1␣ (610958, BD Biosciences), 1:3,000 diluted ␤-actin antiserum (I-19, Santa Cruz Biotechnology, Santa Cruz, CA), 1:100 diluted vascular endothelial growth factor (VEGF; A-20, Santa Cruz Biotechnology), 1:2,000 diluted cyclin D1 (DCS6, Cell Signal, MA), 1:100 diluted cyclin A (C-19, Santa Cruz Biotechnology), 1:3,000 diluted Ndrg1 antiserum (42-6200, Invitrogen, Carlsbad, CA), and 1:1,500 diluted Btg2 antiserum. The intensities of the different bands were analyzed using the GeneTools program of ChemiGenius (Syngene).
Real-time reverse transcription-polymerase chain reaction. Total RNA from cells was isolated using Trizol reagent, and cDNA was synthesized as described previously (12) . Real-time quantitative polymerase chain reaction (qPCR) was performed using the ABI StepOne Plus Real-Time PCR system (Applied Biosystems, Foster City, CA). FAM dye-labeled TaqMan MGB probes and PCR primers were purchased for human Ndrg1 (HS00608387-m1) and Btg2 (HS00198887-m1) from Applied Biosystems. For the internal positive control, glyceraldehyde 3-phosphate dehydrogenase (GAPDH; HS99999905-m1) was used with a FAM reporter dye-labeled TaqMan MGB probe. The amplification conditions were as follows: 40 cycles at 95°C for 15 s and 60°C for 1 min. Mean cycle threshold (C t) values were calculated for GAPDH and the reporter gene using StepOne software version 2.0 (Applied Biosystems). Ct values for Ndrg1 and Btg2 were normalized against the GAPDH control probe to calculate ⌬Ct values. All reactions were preformed in triplicate, and each experiment was conducted on at least three independent occasions. HIF-1␣ expression vector. The human HIF-1␣ cDNA (MGC: 10483) vector was purchased from Invitrogen. Human HIF-1␣ cDNA was linearized by cutting with BamHI and XbaI and ligation with the overexpression vector pcDNA3 (Invitrogen), as previously described (3) .
Knock-down HIF-1␣. LNCaP cells were plated onto six-well plates 1 day before transfection. The culture media were replaced with RPMI-1640 medium plus 10% FCS and 5 g/ml polybrene (Santa Cruz Biotechnology) and then transduced with HIF-1␣ small hairpin RNA lentiviral particles (sc-35561-V; Santa Cruz Biotechnology) as described by the manufacturer. Two days after transduction, the cells (LN-HIF-1␣si) were selected by incubation with 10 g/ml puromycin dihydrochloride for another 3 days. The mock-transfected LNCaP cells (LN-COLsi) were transduced with control small hairpin RNA lentiviral particles (sc-10808-V, Santa Cruz Biotechnology) and were clonally selected in same manner as the LN-HIF-1␣si cells. Cells that expressed HIF-1␣ in resistant colonies were evaluated by the aforementioned immunoblot assay.
Reporter vectors. The reporter vectors containing different fragments of the 5=-flanking region of the human Btg2 gene were cloned as previously described (25) . The DNA fragment containing the promoter of the Ndrg1 gene (Ϫ4,714 to ϩ46) was cloned as previously described (26) . The 5=-deletion of the human Ndrg1 reporter vectors containing different DNA fragments were constructed by digesting with different restriction enzymes. Proper ligation and orientation of the reporter vectors were confirmed by extensive restriction mapping and sequencing.
Transient transfection and reporter assay. LNCaP cells or PC-3 cells were plated onto 24-well plates 1 day before transfection. Cells were transiently transfected using TransFast transfection reagent, as previously described (27) . For the transient cotransfection of HIF-1␣ experiments, cells were transfected with the same amount of plasmid in each well by adding pcDNA3 vector to eliminate variable degrees of efficiency of the reporter activities. Reporter vector-transfected LNCaP or PC-3 cells were then treated with or without L-mimosine in RPMI-1640 medium with 10% FCS for an additional 24 h. The (Fig. 1A) . In the flow cytometric analysis, 100 -800 M of L-mimosine induced a 24.4% increase in G 1 arrest, together with a decrease in G 2 /M phase and S phase cells after 24 h of incubation (Fig. 1B) . However, L-mimosine induced cell apoptosis in PC-3 cells after 48 h of incubation since 100 -800 M of L-mimosine increased the sub-G 1 fraction of cells by 5.9 -20.2% (Fig. 1C) . The immunoblotting assays showed that L-mimosine upregulated Btg2 and Ndrg1 protein levels, but downregulated protein levels of cyclin D1 and cyclin A (Fig. 1D) . The quantitative analysis was done by determining the intensity of each band of different genes and ␤-actin from three independent experiments (Fig. 1E) .
Similar antiproliferative results were also found in the Lmimosine-treated LNCaP cells. L-Mimosine (400 M (Fig. 2A) . However, results from flow cytometric analysis of LNCaP cells revealed that 800 M of L-mimosine induced a 6.5% increase in S phase cell arrest, together with a decrease in G 2 /M phase cells after 24 h of incubation (Fig. 2B) . Eight hundred micromoles of L-mimosine induced a 10.7% increase in S phase arrest after 48 h of incubation (Fig. 2C) . Unlike those studies of PC-3 cells, L-mimosine did not induce cell apoptosis in LNCaP cells, since the sub-G 1 fraction of cells did not differ significantly among cells treated with 0 -800 M of L-mimosine after 24 or 48 h of incubation (Fig. 2, B and C) .
Results of the immunoblotting assays showed that L-mimosine upregulated HIF-1␣, Btg2, and Ndrg1 protein levels in LNCaP cells. However, L-mimosine treatments decreased the protein levels of cyclin A, but did not significantly affect the protein expression of cyclin D1 (P ϭ 0.079, Fig. 2D ). The results of the quantitative analysis are presented in Fig. 2E . Because we found that L-mimosine stabilized HIF-1␣ in both LNCaP and PC-3 cells, we further determined whether the genes induced by L-mimosine could also be induced by hypoxia. The immunoblotting assays revealed that hypoxia, compared with normoxia, significantly upregulated protein levels of HIF-1␣ in both LNCaP and PC-3 cells (Fig. 3, A, left and B,  left) . The results of quantitative analysis indicated that hypoxia stabilized HIF-1␣ and upregulated gene expression of VEGF, Btg2, and Ndrg1 in both LNCaP and PC-3 cells (Fig. 3, A, right  and B, right) . Hypoxic treatment downregulated protein expression of the cyclin A in both LNCaP and PC-3 cells. Interestingly, the quantitative results indicated cyclin D1 levels were downregulated by 51% after 24 h of hypoxic culture compared with PC-3 cells incubated under normoxia (Fig. 3B) . However, we did not find the same phenomenon in the LNCaP cells. Hypoxic treatment increased minimally, but not significantly (P ϭ 0.647), cyclin D1 levels in LNCaP cells (Fig. 3A) .
The results of the immunoblotting assays showed that DMOG, a prolyl 4-hydroxylase inhibitor, at 100 -500 M, stabilized HIF-1␣ and induced Ndrg1 and Btg2 gene expression in LNCaP cells (Fig. 3C, left) . The results of the quantitative analysis indicated that Btg2 and Ndrg1 protein levels were upregulated 2.4-and 3.8-fold, respectively, after treated with 500 M of DMOG for 24 h (Fig. 3C, right) .
The immunoblotting assay revealed that L-mimosine-induced increase in Btg2 gene expression was significantly blocked (P Ͻ 0.01) after cotreatment with FAC, a cell-permeable iron donor (Fig. 4A) . The results of reverse transcription (RT)-qPCR indicated that L-mimosine (400 M) induced a 1.6-fold increase in Btg2 gene expression compared with the solvent-treated group. The transient gene expression assay showed similar results, suggesting that iron blocks the elevation of L-mimosine-induced Btg2 (Fig. 4B) . Furthermore, transient gene expression assays indicated that transient overexpression of HIF-1␣ under normoxia induced Btg2 promoter activity (Fig. 4C) . Induction of transient gene expression using a 5=-deletion assay indicated that HIF-1␣ increased Btg2 promoter activity is dependent on region Ϫ101 to Ϫ1 upstream of the translational initiation site of Btg2 gene (Fig.  4D) . Results of immunoblotting assays and RT-qPCR showed hypoxia induced 1.5-and 2.3-fold increases in Btg2 gene expression, respectively, while cotreatment with chetomin did not sig- (Fig. 4E) .
Transient gene expression assays indicated that L-mimosine induced Ndrg1 promoter activity. L-Mimosine (400 M) induced a 2.09-fold increase in Ndrg1 promoter activity compared with the solvent-treated group (Fig. 5A) . The results of the immunoblotting assay and RT-qPCR indicated that 400 M L-mimosine increased Ndrg1 mRNA levels 1.99-fold compared with the solvent-treated group. Furthermore, this increase was significantly blocked (P Ͻ 0.01) by cotreatment with FAC, indicating that iron blocks the elevation of Lmimosine-induced Ndrg1 (Fig. 5B) . Similar results were found in the transient gene expression assays (Fig. 5C) . Induction of transient gene expression using a 5=-deletion assay indicated that L-mimosine induced an increase in Ndrg1 promoter activity, which was dependent on the DNA fragment located at Ϫ4,714 to Ϫ1,319 upstream of the transcriptional initiation site of the Ndrg1 gene (Fig. 5D) .
The results of RT-qPCR showed that hypoxia increased Ndrg1 mRNA levels 6.35-fold compared with cells cultured under normoxia; however, this increased effect was significantly attenuated (P Ͻ 0.01) by cotreatment with chetomin (Fig. 6A) . Similar results were found in the immunoblotting assays. Hypoxia increased Ndrg1 and VEGF protein levels, while chetomin blocked the increases (Fig. 6B) . Transient gene expression assays revealed that transient overexpression of HIF-1␣ enhanced Ndrg1 promoter activity (Fig. 6C) . Induction of transient gene expression using a 5=-deletion assay indicated that transient overexpression of HIF-1␣ increased Ndrg1 promoter activity, which was also dependent on region Ϫ4,714 to Ϫ1,319 upstream of the transcriptional initiation site of the Ndrg1 gene (Fig. 6D) .
To determine whether the upregulation of Btg2 and Ndrg1 in prostate carcinoma cells by hypoxia or L-mimosine was HIF-1␣ dependent, we transiently knocked down HIF-1␣ in LNCaP (LN-HIF-1␣si ) cells. The immunoblotting assays revealed that hypoxia, compared with normoxia, significantly upregulated (P Ͻ 0.001) protein levels of Btg2 and Ndrg1 in mock-transfected LNCaP (LN-COLsi) cells. However, the increase in protein levels of both Btg2 and Ndrg1 by hypoxia was significantly attenuated (P Ͻ 0.001) when the HIF-1␣ gene was knocked down from LNCaP (LN-HIF-1␣si) cells (Fig. 7A) . Similar results were also found for L-mimosine treatment (Fig. 7B) .
DISCUSSION
L-Mimosine, a plant amino acid, reversibly blocks mammalian cell cycle at the late G 1 phase (5). Earlier studies using prostate DU145 carcinoma cells revealed that numbers of G 0 /G 1 cells were elevated after incubation with L-mimosine, resulting in upregulation of p27 (32) . Our results indicated that L-mimosine inhibited PC-3 cell proliferation with increasing numbers of cells accumulating in the G 1 phase of the cell cycle. Moreover, L-mimosine induced cell apoptosis when PC-3 cells were treated with L-mimosine for long period of incubation (48 h). Consistent with previous studies, these results showed that L-mimosine exerted apoptotic activity in human pancreatic cancer and 937 leukemia cells (9, 35) . With LNCaP cells, the numbers of S phase cells were elevated after incubation with L-mimosine. These results are in agreement with early studies indicating that L-mimosine reversibly arrested the cell cycle late in the G 1 phase or at the beginning of the S phase (10). Our flow cytometric analysis indicated that L-mimosine (800 M) suppressed cell growth but did not exert apoptotic activity in human prostate carcinoma LNCaP cells in vitro. Results of our Cyclin D1 serves as a key sensor and an integrator of extracellular signals and promotes progression through G 1 -S phases of the cell cycle (7). Our in vitro study using PC-3 cells showed that hypoxia or L-mimosine treatment inhibited the expression of cyclin D1. This result is similar to the results of early studies that indicated L-mimosine blocked cell cycle progression and suppressed proliferation of H226 lung cancer cells and human breast cancer MDA-MB-453 cells by inhibition of cyclin D1 expression (2, 14) . Our results also are in agreement with results of other studies that indicated the inverse association between cyclin D1 and HIF-1␣ in A549 pulmonary cancer cells and bone marrow-derived mesenchymal stem cells (20, 33) . However, unlike in PC-3 cells, hypoxia or L-mimosine treatment increased cyclin D1 expression slightly but not significantly in LNCaP cells. In 3T3 cells, L-mimosine arrested cells in the G 1 phase, but did not affect the protein levels of cyclin D1 (29) . Additionally, hypoxia enhanced cyclin D1 gene expression in human breast carcinoma MCF-7 cells (11). It appears that hypoxic effects on cyclin D1 expression are cell type dependent. It is worthy to note that LNCaP cells are p53-wild-type cells, and PC-3 cells are p53-null cells (27) . p53 is a well-known regulator of the G 1 /S and G 2 /M check points (18) . The difference in p53 expression between LNCaP and PC-3 cells could account for the differences in cyclin D1 expression and cell cycle arrest under hypoxic conditions. Our results also showed that L-mimosine treatment inhibited the expression of cyclin A in both PC-3 and LNCaP cells, which is consistent with results of other studies that indicated hypoxia or L-mimosine treatment downregulated the expression of cyclin A (21, 24) . These results may also account for cell cycle arrest in S phase by L-mimosine in LNCaP cells. Induction of Btg2 led to G 1 cell cycle arrest in several cell lines (8, 23, 25) . Loss of Btg2 expression is the earliest known indicator that a cell cycle regulator is lost in prostate carcinogenesis (6); nonetheless, the function and regulatory mechanisms of Btg2 in the human prostate are still unclear. In a previous study using stable Btg2 overexpressing PC-3 cells, we found that overexpression of Btg2 attenuated cell proliferation; moreover, Btg2 gene expression was downregulated by thyroid hormone in prostate carcinoma LNCaP cells (25) . In the present study, upregulation of Btg2 gene expression by Lmimosine in PC-3 cells led to attenuated cell proliferation and cell cycle arrest in phase G 1 . The effect of L-mimosine on Btg2 in our study was mediated by iron depletion, since its modulation was reversed by adding iron. We also found that hypoxia enhanced Btg2 gene expression, and HIF-1␣ enhanced the promoter activity of the Btg2 reporter vector. Our results are in agreement with another study in which hypoxia induced increased Btg2 and decreased cyclin D1 expression in bone marrow-derived mesenchymal stem cells (20) . Induction of transient gene expression by 5=-deletion assay indicated that HIF-1␣-increased Btg2 promoter activity was dependent on the Ϫ101 to Ϫ1 region upstream of the translational initiation site of the Btg2 gene. Nonetheless, our RT-qPCR and immunoblot data showed that chetomin did not significantly affect hypoxiainduced Btg2 expression. Chetomin is a small molecule that disrupts the CH1 domain of p300, precluding its interaction with HIF-1␣, and thus its subsequent transcriptional activity (15) . Additionally, we did not find a conserved DNA sequence (5=-RCGTG-3=) of HIF-1␣ response element (30) in the Btg2 promoter region (Ϫ297 to Ϫ1) when using simple sequence analysis with the GCG program (http://bioinfo.nhri.org.tw). Taken together, we suggest that enhancement of Btg2 gene expression by L-mimosine occurs via an HIF-1␣ indirect pathway.
Previous study identified that induction of Ndrg1, which is essential for the G 1 phase arrest, is an early event after L-mimosine treatment (4). Although L-mimosine is similar to other iron chelators inducing Ndrg1 gene expression in several cell lines (34) , our study is the first to characterize L-mimosineinduced Ndrg1 gene expression in prostate carcinoma cells. Moreover, we found that gene expression of Ndrg1 increased when LNCaP cells were treated with other prolyl hydroxylase inhibitors, such as DMOG. The effect of L-mimosine on Ndrg1 in our study was mediated by iron depletion, because it was reversed by adding iron, which is in agreement with other studies (16, 17) . RT-qPCR and immunoblotting assays showed that chetomin suppressed hypoxia-induced Ndrg1 expression. In combination with the transient gene expression assay, our data suggested that direct HIF-1␣ binding to the putative response element on the Ndrg1 genes is involved in the mediation of HIF-1␣ on Ndrg1 gene expression. The actual mechanism responsible for the effect of HIF-1␣ on the Ndrg1 gene is still not well known. A previous study indicated that hypoxia-inducible transcription of the Ndrg1 gene is dependent on the activation of c-Jun/AP-1 transcription factor or Egr1/ Sp1 binding site located Ϫ80 to Ϫ50 upstream of the transcriptional initiation site of the Ndrg1 gene (36) . Our results suggest that induction of Ndrg1 gene expression by hypoxia is dependent on the binding of the HIF-1␣ on the putative HIF-1␣ response element located Ϫ4,714 to Ϫ1,319 bp upstream of the transcriptional initiation site of the Ndrg1 gene. Our results are in agreement with previous studies that determined the putative HIF-1␣ response element of the Ndrg1 gene based on bioinformatic analysis (4, 13, 16) . Moreover, our results (Fig. 7) indicated that the increasing of protein levels of both Btg2 and Ndrg1 by hypoxia is attenuated when the HIF-1␣ gene was knocked down in LNCaP cells, suggesting that the upregulation of Btg2 and Ndrg1 in prostate carcinoma cells by hypoxia is dependent on HIF-1␣.
In conclusion, the results suggest that L-mimosine treatment and hypoxia modulate the expression of Btg2 and Ndrg1 genes through different mechanisms. L-Mimosine stabilizes HIF-1␣ protein and enhances expression of Btg2 and Ndrg1 at the transcriptional level, which attenuates cell proliferation of prostate carcinoma cells in vitro.
